Johnson & Johnson's one-shot COVID-19 vaccine is 85 percent effective against severe illness, and could be far easier to deploy. The J&J vaccine and an additional vaccine candidate by Novavax could alleviate access challenges for women frontline workers.https://19thnews.org/2021/01/for-women-workers-new-covid-vaccines-candidates-could-alleviate-access-challenges/?utm_campaign=19th-social&utm_content=johnson__johnsons_one-sho&utm_medium=social&utm_source=twitter …
